obsolete_cleft palate: ['Congenital fissure of the soft and/or hard palate, due to faulty fusion.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
519447 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
402 |
4. Check minimum number of eventsNone |
402 |
5. Include endpointsNone |
402 |
6. Filter based on genotype QC (FinnGen only) |
402 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CLEFT_LIP_CLEFT_PALATE
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Cleft palate
based on the number of shared cases.
Similar with more cases:
- Cleft lip, lip and palate or palate
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5369 | 3001 | 2360 |
| Only index persons | 4471 | 2522 | 1949 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.09 | 0.07 |
| Only index persons | 0.08 | 0.09 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 1.83 | 1.71 | 1.86 |
| Only index persons | 1.89 | 1.81 | 1.99 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 402 | 277 | 125 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.06 |
| Median age at first event (years) | 2.69 | 2.03 | 4.15 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 371
- Matched controls
- 3709
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q35.1
ICD-10 Finland
Cleft hard palate
3014.5
189.6
167
*
74900
ICD-8 Finland
Cleft palate and cleft lip, Cleft palate
+∞
182.9
160
*
7490A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]
+∞
82.4
76
*
4364
FHL
Pharyngeal tongue plastic
+∞
75.7
70
*
4362
FHL
Nozzle reconstruction
+∞
58.9
55
*
4122
FHL
Tympanostomy (tympanic tube)
19.8
58.0
90
59
Q35.71
ICD-10 Finland
Submucous cleft palate
+∞
50.1
47
*
Q35.9
ICD-10 Finland
Cleft palate, unspecified
546.0
49.6
48
*
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
519.9
47.4
46
*
7490C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS SUBMUCOSAE]
+∞
42.5
40
*
7490B
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS INCOMPLETA]
+∞
41.4
39
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
13.1
35.4
64
58
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
10.4
32.9
67
77
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
7.6
28.4
70
110
SAA04
NOMESCO Finland
Special inverstigation of mouth
7.2
28.0
72
120
EB1MA
NOMESCO Finland
Cephalometry with X-ray
9.0
27.0
59
76
Q35.3
ICD-10 Finland
Cleft soft palate
+∞
26.4
25
*
SBB10
NOMESCO Finland
Teeth copy
5.2
25.8
89
214
7492A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS UNILATERALIS COMPLETA]
+∞
24.2
23
*
74920
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis unilateralis
+∞
24.2
23
*
4361
FHL
Lip plastic or reconstruction due to cleft lip
+∞
23.2
22
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
7.7
22.9
55
82
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.4
22.6
51
69
4451
FHL
Guitar cutting
5.7
21.3
65
134
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
30.1
21.3
28
10
4368
FHL
Closing the fistula of the mouth
+∞
21.0
20
*
1450
FHL
Otomicroscopy
25.1
20.3
28
12
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
13.2
20.0
35
29
Q37.0
ICD-10 Finland
Cleft hard palate with bilateral cleft lip
+∞
20.0
19
*
EBB10
NOMESCO Finland
Insertion of dental implant
24.1
19.4
27
12
EHC40
NOMESCO Finland
Correction of submucous cleft palate
+∞
18.9
18
*
EHC10
NOMESCO Finland
Plastic repair of oronasal or oroantral fistula of palate
+∞
18.9
18
*
EEC05
NOMESCO Finland
Le Fort I osteotomy
99.9
17.7
19
*
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
15.8
17.4
28
19
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
6.5
17.0
45
77
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
66.5
16.9
19
*
EAB30
NOMESCO Finland
Correction of cleft lip
+∞
16.8
16
*
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
6.7
16.0
41
67
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
6.5
16.0
42
71
UDC00
NOMESCO Finland
Ear microscopy
5.1
15.5
50
109
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
6.3
14.9
40
70
K00.00
ICD-10 Finland
Hypodontia
11.6
14.7
27
25
ECB17
NOMESCO Finland
Operation for cleft gingiva
+∞
13.6
13
*
74929
ICD-8 Finland
Cleft palate and cleft lip, Unspecified
+∞
13.6
13
*
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
51.9
12.9
15
*
4365
FHL
Correction of nasal deformity
+∞
12.6
12
*
ENC80
NOMESCO Finland
Plastic operation of soft palate for voice distubance
134.3
12.5
13
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.3
12.5
66
226
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
38.9
12.3
15
*
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
6.7
12.3
31
50
EBB15
NOMESCO Finland
Insertion of dental implant abutment
27.8
12.1
16
6
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
5.5
11.9
35
69
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
6.2
11.6
31
54
4367
FHL
Bone transfer to the upper jaw
+∞
11.5
11
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.4
11.4
41
101
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
7.8
11.1
25
34
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
44.7
11.0
13
*
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
44.7
11.0
13
*
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
29.0
10.8
14
5
H66.9
ICD-10 Finland
Otitis media, unspecified
3.3
10.8
56
189
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
11.7
10.7
19
17
ZSZ10
NOMESCO Finland
Secondary repair operation
113.1
10.5
11
*
7492C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS BILATERALIS COMPLETA]
+∞
10.5
10
*
Q35.70
ICD-10 Finland
Cleft uvula
+∞
10.5
10
*
74924
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis bilateralis
+∞
10.5
10
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.1
10.3
59
213
SAA03
NOMESCO Finland
Extended examination of mouth
2.1
10.3
183
1188
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
6.6
10.0
25
40
SJB60
NOMESCO Finland
External device grinding and adaptation
6.7
9.7
24
38
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
30.9
9.5
12
*
Q35
ICD-10 Finland
Cleft palate
+∞
9.4
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
9.3
136
803
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
4.3
9.1
33
82
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
37.7
9.1
11
*
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
37.7
9.1
11
*
4141
FHL
Myringoplasty (also for reasons other than inflammation)
24.7
9.0
12
5
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
6.2
8.9
23
39
ZXB10
NOMESCO Finland
Medial
14.5
8.8
14
10
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
51.2
8.7
10
*
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
51.2
8.7
10
*
EHC30
NOMESCO Finland
Reconstruction of palate
92.0
8.4
9
*
R1260
NOMESCO Finland
Evaluation of communicative skills
13.2
8.4
14
11
9808
FHL
Bone graft
+∞
8.4
8
*
Q36.9
ICD-10 Finland
Cleft lip, unilateral
+∞
8.4
8
*
DLW00
NOMESCO Finland
Correction of cleft nose
+∞
8.4
8
*
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
5.8
8.1
22
40
H74.1
ICD-10 Finland
Adhesive middle ear disease
34.1
8.1
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
8.0
130
793
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
4.9
7.5
23
49
4347
FHL
Osteotomy of the upper jaw
81.6
7.4
8
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
7.4
166
1129
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
+∞
7.3
7
*
74912
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathoschisis unilateralis
+∞
7.3
7
*
Q35.7
ICD-10 Finland
Cleft uvula
+∞
7.3
7
*
K07.14
ICD-10 Finland
Retrognaty, maxillary
16.1
7.3
11
7
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
7.5
7.3
16
22
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
30.6
7.2
9
*
EB1WA
NOMESCO Finland
NA
20.5
7.2
10
5
Z2221
NOMESCO Finland
Medical doctor
2.0
7.1
115
694
DCD00
NOMESCO Finland
Myringoplasty
10.3
7.1
13
13
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
3.7
7.1
29
82
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
7.0
206
1523
R4130
NOMESCO Finland
Speech therapy
7.8
7.0
15
20
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
7.0
117
716
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
8.5
6.9
14
17
ZXA10
NOMESCO Finland
Bilateral
2.3
6.9
67
325
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
17.1
6.8
10
6
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
23.0
6.7
9
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
23.0
6.7
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
6.5
95
548
R49.2
ICD-10 Finland
Hypernasality and hyponasality
71.0
6.4
7
*
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
71.0
6.4
7
*
SPF20
NOMESCO Finland
Temporary soling for filling
71.0
6.4
7
*
38400
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) acuta
71.0
6.4
7
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
6.7
6.4
15
23
EH1JB
NOMESCO Finland
Functional examination of palate
+∞
6.3
6
*
Q37.99
ICD-10 Finland
Cleft palate with cleft lip NOS
+∞
6.3
6
*
4363
FHL
Hidden slit reconstruction
+∞
6.3
6
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.7
6.1
25
71
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
6.9
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
60
350
1.84
4.22
1.7
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
48
2.77
2.74
1.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
16
4.43
2.48
1.1
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
29
168
1.78
2.14
8.9
12.9
g/l
123.9
124.1
0.01
24
159
(3026389) Candida sp identified in Specimen by Organism specific culture
11
43
2.60
2.11
1.5
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
32
196
1.69
1.97
9.4
12.9
mmol/l
1.4
0.8
0.42
22
148
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
29
2.79
1.80
1.1
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
20
110
1.86
1.76
4.4
11.7
mmol/l
25.0
24.2
0.57
15
101
(3023183) Ammonium ion [Moles/volume] in Plasma
0
48
0.00
1.71
0.0
6.9
—
42.2
—
0
42
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
77
1.98
1.61
1.1
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
20
115
1.78
1.55
13.2
14.1
%
0.8
0.7
0.34
20
115
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
20
115
1.78
1.55
13.2
14.0
%
1.5
1.5
0.05
20
115
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
21
2.88
1.51
1.0
4.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
21
2.88
1.51
1.0
1.1
miu/ml
1616.0
1683.3
—
6
21
(3052851) Hemolysis interference index of Serum or Plasma
14
72
1.98
1.50
4.2
3.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
102
1.80
1.47
12.6
19.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
22
2.75
1.44
1.0
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
44
316
1.44
1.41
1.3
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
19
112
1.73
1.38
13.6
14.4
%
96.2
94.7
1.42
19
112
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
82
1.86
1.37
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
23
2.63
1.37
1.0
2.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
23
2.63
1.37
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
17
2.96
1.36
1.2
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
40
0.00
1.33
0.0
5.4
—
72.1
—
0
12
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
44
2.07
1.27
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
13
70
1.89
1.25
6.4
5.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
96
796
1.27
1.22
8.6
6.2
inr
1.2
1.1
0.42
28
280
(3011397) Hemoglobin [Presence] in Urine by Test strip
83
677
1.28
1.20
3.2
3.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
35
479
0.70
1.17
1.7
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
150
1.57
1.17
1.7
1.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
20
2.52
1.15
1.2
1.8
g/l
1.0
0.9
—
5
20
(3019550) Sodium [Moles/volume] in Serum or Plasma
326
3102
1.27
1.09
10.3
10.2
mmol/l
139.5
139.5
0.24
317
3008
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
41
1.97
1.09
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
17
106
1.63
1.04
3.4
9.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
75
902
0.79
1.03
2.1
2.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
176
1583
1.20
1.02
4.7
5.2
mmol/l
6.2
6.3
0.31
159
1406
(3029396) Erythrocyte agglutination [Presence] in Blood
5
23
2.19
0.98
6.2
3.6
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
11
62
1.80
0.95
1.7
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
84
988
0.81
0.94
2.2
2.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
116
1012
1.21
0.92
4.8
5.4
g/l
36.3
37.5
1.44
110
957
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
101
0.49
0.90
1.2
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
325
3112
1.23
0.89
10.4
10.2
mmol/l
3.9
3.9
0.23
313
3005
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
178
1.43
0.88
2.7
5.0
mmol/l
0.9
1.0
0.06
16
123
(3022145) Colonoscopy Study observation
36
274
1.34
0.87
1.6
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
387
3795
1.57
0.87
15.4
14.9
e9/l
271.1
260.6
2.51
380
3713
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
31
1.95
0.84
1.2
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
31
1.95
0.84
1.2
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
51
626
0.79
0.84
2.5
2.8
umol/l
329.0
3786.5
1.74
45
576
(3021601) Nitrite [Presence] in Urine by Test strip
169
1537
1.17
0.83
5.1
4.4
estimate
0.0
0.0
0.50
27
309
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
291
3045
0.84
0.82
3.1
3.3
mmol/l
1.5
1.5
0.03
277
2895
(3026361) Erythrocytes [#/volume] in Blood
387
3798
1.54
0.82
15.3
14.9
e12/l
4.6
4.6
0.35
381
3711
(3041806) Other cells [#/volume] in Blood by Manual count
6
32
1.89
0.82
2.0
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
43
535
0.78
0.79
4.4
2.6
ug/g
148.3
90.1
0.58
37
418
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
135
1209
1.18
0.79
3.5
3.1
—
—
—
0
0
(3012544) pH of Venous blood
29
217
1.36
0.79
7.1
8.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
73
854
0.82
0.78
1.5
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
387
3801
1.52
0.78
15.4
14.9
e9/l
6.9
6.7
1.21
381
3708
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
22
301
0.72
0.78
1.5
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
28
0.00
0.76
0.0
1.1
—
1.1
—
0
10
(3037467) Urinalysis macro (dipstick) panel - Urine
230
2153
1.16
0.75
4.1
3.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
24
2.10
0.74
8.6
4.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
22
298
0.72
0.74
1.5
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
44
540
0.79
0.73
1.2
1.3
u/ml
18.0
8.4
0.36
21
222
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
36
453
0.77
0.73
2.4
2.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
26
194
1.36
0.73
13.7
12.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
45
364
1.27
0.73
2.0
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
293
3052
0.85
0.71
3.1
3.3
mmol/l
4.8
4.7
0.75
277
2906
(3040151) Glucose [Moles/volume] in Capillary blood
5
26
1.93
0.71
8.0
11.7
mmol/l
6.1
6.6
—
5
20
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
85
970
0.84
0.70
1.2
1.3
u/ml
0.8
1.6
0.95
24
243
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
13
85
1.55
0.69
7.4
4.3
%
56.7
52.1
0.30
13
85
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
119
0.58
0.68
1.6
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
167
0.65
0.67
1.1
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
82
714
1.19
0.67
2.9
3.0
e6/l
0.4
0.2
0.44
68
523
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
296
3076
0.86
0.67
3.3
3.5
mmol/l
3.0
2.9
0.87
279
2906
(3003694) ABO and Rh group [Type] in Blood
104
1163
0.86
0.66
1.9
1.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
323
3118
1.18
0.66
13.0
12.8
g/l
333.8
334.1
0.24
316
3099
(3007164) IgA [Mass/volume] in Serum or Plasma
76
871
0.84
0.66
1.3
1.4
g/l
2.0
2.1
0.26
53
551
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
713
0.83
0.65
1.5
1.6
mmol/l
1.2
1.3
1.12
55
636
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
23
172
1.36
0.65
13.0
11.2
mmol/l
25.5
24.8
0.53
23
172
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
127
0.62
0.65
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
280
2919
0.86
0.65
2.8
3.0
mmol/l
1.3
1.2
0.54
266
2768
(3035350) Ketones [Presence] in Urine by Test strip
167
1543
1.14
0.63
3.5
3.1
estimate
0.0
0.0
0.00
28
299
(3014111) Lactate [Moles/volume] in Serum or Plasma
24
182
1.34
0.63
13.5
11.6
mmol/l
1.1
1.4
1.28
24
171
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
13
187
0.68
0.62
1.5
1.7
mg/l
3.1
2.8
—
7
119
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
30
1.67
0.61
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
30
1.67
0.61
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
30
1.67
0.61
1.2
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
17
232
0.72
0.61
1.8
3.8
pmol/l
4.8
4.8
0.09
17
206
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
115
1037
1.15
0.61
6.7
7.4
mmol/l
1.2
1.2
0.38
102
954
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
10.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
320
0.77
0.60
1.2
1.3
iu/ml
38.6
172.6
4.06
11
135
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
22
0.00
0.59
0.0
1.0
—
99.3
—
0
15
(42529406) Shigella sp [Presence] in Stool by Culture
7
111
0.62
0.59
1.1
1.3
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
23
0.00
0.58
0.0
1.0
—
91.9
—
0
16
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
252
0.74
0.58
1.9
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
168
1560
1.13
0.58
3.6
3.2
estimate
0.0
0.0
0.50
28
293
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
132
1.38
0.58
1.5
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
173
1611
1.13
0.57
6.7
6.1
e9/l
0.0
0.0
0.42
156
1423
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
565
0.83
0.56
1.3
1.3
iu/ml
18.4
22.8
0.21
15
182
(3023511) Choriogonadotropin [Units/volume] in Urine
14
194
0.71
0.56
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
37
1.63
0.55
2.0
3.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
25
195
1.30
0.55
3.6
4.6
%
0.0
0.1
—
5
40
(3001604) Monocytes [#/volume] in Blood
172
1605
1.13
0.54
6.8
6.1
e9/l
0.6
0.5
0.97
157
1421
(3021440) Promyelocytes/100 leukocytes in Blood
26
205
1.29
0.54
4.3
4.5
%
0.0
0.1
—
6
52
(36304419) Bacteria [Presence] in Urine
82
729
1.16
0.53
2.5
3.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
6
39
1.55
0.53
4.8
2.4
mmol/l
8.2
6.6
—
6
39
(3001122) Ferritin [Mass/volume] in Serum or Plasma
176
1647
1.12
0.52
3.0
2.9
ug/l
71.4
75.4
0.23
169
1557
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
97
0.61
0.52
1.2
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
43
507
0.83
0.52
1.5
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
42
353
1.21
0.52
2.6
2.4
g/l
2.3
2.4
0.49
37
322
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
226
2371
0.89
0.51
3.0
3.1
u/l
30.0
35.0
1.84
218
2277
(3013707) Erythrocyte sedimentation rate by Westergren method
213
2242
0.89
0.51
4.0
3.7
mm/h
10.1
8.4
1.04
201
2101
(3019198) Lymphocytes [#/volume] in Blood
178
1669
1.12
0.51
6.7
6.1
e9/l
2.0
2.0
0.10
166
1501
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
49
419
1.19
0.51
2.6
3.0
ng/l
409.8
677.1
0.23
25
231
(3018405) Lactate [Moles/volume] in Arterial blood
9
65
1.39
0.51
4.1
5.2
mmol/l
1.3
1.4
—
9
65
(3002523) Influenza virus A Ag [Presence] in Specimen
14
101
1.40
0.50
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
101
1.40
0.50
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
107
0.65
0.49
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
106
0.65
0.49
1.1
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
102
927
1.13
0.49
3.2
3.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
27
218
1.26
0.48
4.2
4.4
%
0.8
0.9
—
6
59
(3022313) Gas panel - Capillary blood
19
146
1.32
0.48
2.9
5.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
48
1.47
0.47
1.4
1.1
—
—
—
0
0
(3013512) EKG study
51
585
0.85
0.46
3.8
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
53
606
0.86
0.46
1.8
1.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
207
2174
0.90
0.46
6.8
6.6
u/l
87.4
77.0
0.40
196
2041
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
89
807
1.13
0.44
1.5
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
25
202
1.25
0.44
3.7
4.3
%
0.0
0.8
—
5
36
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
62
698
0.87
0.44
1.9
2.0
u/l
153.2
275.7
0.66
56
664
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
47
540
0.85
0.44
2.4
1.8
%
1.4
1.4
0.13
42
502
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
337
3293
1.15
0.43
11.0
10.3
mg/l
22.1
19.8
0.56
266
2469
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
31
1.62
0.43
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
31
1.62
0.43
1.2
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
56
1.44
0.43
1.3
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
32
1.57
0.42
1.2
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
8
57
1.41
0.42
2.0
4.9
umol/l
332.0
372.7
—
8
49
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
222
1.23
0.42
2.2
2.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
38
324
1.19
0.42
1.6
1.5
nmol/l
1010.8
1204.4
0.76
29
257
(3002582) Erythrocytes [#/volume] in Urine
88
801
1.13
0.42
2.9
3.1
e6/l
50.4
38.8
0.18
73
603
(3026008) Bacteria identified in Urine by Culture
87
792
1.13
0.41
2.7
2.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
15
0.00
0.41
0.0
2.7
—
120.7
—
0
15
(3028433) Virus identified in Specimen by Culture
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
159
1.27
0.41
1.4
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
34
1.48
0.40
1.0
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
4.6
—
1.7
—
0
18
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
280
0.81
0.40
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
280
0.81
0.40
1.5
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
3.2
—
662.2
—
0
19
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(4024509)
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
279
0.81
0.38
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
279
0.81
0.38
1.5
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
108
1000
1.11
0.38
3.4
3.6
e6/l
93.9
68.3
0.15
79
651
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
136
0.73
0.38
1.9
2.0
u/l
37.2
41.2
—
10
125
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
125
1167
1.10
0.38
7.0
7.8
mmol/l
1.2
1.2
0.37
110
1000
(3013650) Neutrophils [#/volume] in Blood by Automated count
194
1850
1.09
0.38
8.2
8.8
e9/l
4.3
3.9
1.47
173
1620
(3045414) Leukocytes [Presence] in Urine
8
114
0.70
0.37
1.6
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
212
0.79
0.36
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
71
1.27
0.36
1.4
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
126
1.28
0.35
1.3
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
249
2573
0.91
0.35
3.7
4.1
mmol/mol
37.8
37.7
0.07
236
2456
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
124
0.72
0.35
2.0
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
4.2
4.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
62
560
1.13
0.34
2.9
3.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
33
381
0.85
0.34
2.5
2.4
mmol/l
2.4
2.4
0.33
27
330
(4034850)
12
91
1.33
0.34
5.1
7.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
278
2855
0.91
0.33
3.0
3.2
mmol/l
5.6
5.6
0.01
263
2675
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
23
273
0.83
0.32
2.2
3.0
%
31.2
32.7
0.27
18
191
(3044889) 12 lead EKG panel
173
1810
0.92
0.32
2.7
2.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
202
1.20
0.32
1.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
229
0.82
0.31
1.6
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
175
1673
1.08
0.31
7.1
6.5
e9/l
0.2
0.2
0.81
160
1494
(3019225) pH of Specimen
17
207
0.81
0.31
3.3
4.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
55
1.28
0.30
11.0
4.5
e9/l
5.4
4.1
—
7
55
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
56
1.25
0.29
11.0
4.6
%
63.7
57.5
—
7
56
(3002385) Erythrocyte distribution width [Ratio]
303
2964
1.09
0.29
12.9
12.5
%
13.4
13.3
0.16
298
2919
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
106
0.75
0.29
1.6
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
15
184
0.81
0.29
1.5
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
24
280
0.85
0.29
1.6
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
57
519
1.11
0.28
2.5
2.5
mosm/kgh2o
620.5
577.2
0.51
52
436
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
94
1.29
0.28
1.3
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
140
1.22
0.28
1.5
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
63
1.28
0.28
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
337
3315
1.10
0.27
12.2
11.2
%
39.9
40.7
1.20
283
2816
(3047352) Trisomy 18 risk [Likelihood] in Fetus
19
225
0.84
0.27
1.6
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
43
477
0.89
0.27
1.3
1.4
titre
205.0
440.0
—
8
92
(3004119) Hemoglobin [Mass/volume] in Venous blood
14
113
1.25
0.27
8.6
7.5
g/l
124.9
129.9
0.47
14
113
(3021589) Normoblasts [#/volume] in Blood
138
1447
0.93
0.27
9.4
8.0
e9/l
0.0
0.0
1.09
113
1175
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
320
0.87
0.27
1.4
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
18
214
0.83
0.26
1.4
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
171
0.81
0.26
2.1
2.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
5
74
0.67
0.26
2.0
2.2
mg/l
8.3
9.1
—
5
67
(3005033) Fetal Nuchal fold Thickness US
19
224
0.84
0.26
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
125
1314
0.93
0.26
2.3
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
129
1353
0.93
0.25
4.3
6.1
umol/l
11.6
10.6
0.25
121
1290
(3041096) Erythrocytes [Presence] in Urine by Automated
99
933
1.08
0.25
3.2
2.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
198
1.17
0.25
1.6
2.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
19
223
0.84
0.25
1.2
1.2
—
20.1
—
0
12
(3044640) Blood type and Crossmatch panel - Blood
98
924
1.08
0.25
2.1
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
76
1.19
0.25
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
72
670
1.09
0.24
2.9
2.3
mg/l
2.7
2.7
0.02
66
578
(3021879) Hepatitis B virus core Ab [Presence] in Serum
41
370
1.12
0.24
1.4
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
31
347
0.88
0.23
1.0
1.2
—
—
—
0
0
(4035726)
23
200
1.16
0.23
1.5
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
18
210
0.85
0.22
1.8
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
87
820
1.08
0.22
5.3
4.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
105
997
1.07
0.22
7.0
6.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
249
2547
0.94
0.21
3.8
4.0
pmol/l
14.4
14.4
0.06
236
2380
(3005011) Chlamydia sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
7.6
—
0
11
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.5
—
79.0
—
0
11
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
3.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
3.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
356
3520
1.10
0.21
9.7
9.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
31
345
0.89
0.21
1.4
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
78
734
1.08
0.21
3.1
3.3
mmol/l
8.7
8.5
0.08
66
653
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
43
1.16
0.21
2.6
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
261
0.87
0.21
1.0
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
10
123
0.81
0.20
4.4
4.6
%
89.1
91.8
—
10
118
(3049717) Cytology report of Urine Cyto stain
6
48
1.25
0.20
1.5
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
48
1.25
0.20
1.5
2.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
50
1.20
0.20
5.5
3.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
65
609
1.08
0.19
1.6
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
74
698
1.07
0.19
3.4
3.3
kg/l
1.0
1.0
—
10
93
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
128
1.18
0.18
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
294
2985
0.94
0.18
4.2
4.5
mu/l
1.8
1.7
0.33
283
2829
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
60
1.17
0.18
6.1
7.4
—
3848.6
—
0
7
(21494755) Public health laboratory ask at order entry panel
58
545
1.08
0.17
1.3
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
162
1573
1.05
0.16
6.5
5.9
%
57.7
55.5
1.63
152
1496
(40761535) Cells panel - Urine sediment
21
187
1.13
0.16
3.3
3.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
29
264
1.11
0.16
4.0
5.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
111
1.18
0.16
2.8
2.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
157
1525
1.05
0.16
7.1
6.1
%
2.7
2.8
0.09
148
1435
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
77
0.78
0.15
1.0
1.6
mmol/l
3.3
3.5
—
6
72
(3015377) Calcium [Moles/volume] in Serum or Plasma
82
858
0.94
0.15
2.3
3.1
mmol/l
2.4
2.4
0.17
66
780
(3028300) Cannabinoids [Presence] in Urine
30
327
0.91
0.15
1.5
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
87
0.80
0.14
1.3
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
22
198
1.12
0.14
1.8
1.8
g/l
1.7
1.3
0.49
22
184
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
18
202
0.89
0.14
1.9
1.9
ug/l
0.5
0.7
—
8
88
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
150
1459
1.04
0.14
4.1
4.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
163
1589
1.04
0.14
7.1
6.0
%
28.6
30.3
1.32
155
1513
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
97
0.82
0.14
1.5
1.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
47
442
1.07
0.13
1.9
1.6
pmol/l
441.4
55303461.6
1.07
41
396
(3022096) Basophils/100 leukocytes in Blood
151
1470
1.04
0.13
7.2
6.2
%
0.6
0.7
0.74
141
1381
(3025941) Bacteria identified in Stool by Culture
22
199
1.11
0.13
1.6
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
157
1530
1.04
0.13
7.4
6.3
%
8.0
8.1
0.04
149
1451
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
107
0.84
0.13
2.3
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
110
0.81
0.13
2.4
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
30
324
0.92
0.13
1.5
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
229
1.10
0.12
1.4
1.4
miu/ml
180.2
280.6
1.08
15
123
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
200
1.11
0.12
1.6
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
22
241
0.91
0.12
2.3
2.2
—
22.5
—
0
18
(3000764) Benzodiazepines [Presence] in Urine
30
323
0.92
0.12
1.5
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
30
323
0.92
0.12
1.5
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
113
1162
0.96
0.11
1.8
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
136
0.88
0.11
1.3
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
306
3030
1.04
0.10
4.0
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
80
772
1.05
0.10
6.2
6.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
26
241
1.08
0.10
1.8
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
115
1.13
0.10
2.0
1.5
u/ml
95.0
220.6
—
8
68
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
44
1.14
0.10
1.2
1.4
nmol/l
29.9
35.5
—
5
34
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
2.2
2.4
—
—
—
0
0
(1002224) Polysomnography panel
16
176
0.91
0.09
1.1
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
83
804
1.04
0.09
3.2
2.7
ng/l
33.1
54.1
0.37
44
343
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
25
268
0.93
0.09
2.5
2.9
%
16.0
22.9
—
7
79
(40761536) Microorganisms panel - Urine sediment
29
272
1.07
0.09
3.3
3.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
126
1233
1.03
0.08
2.7
2.5
nmol/l
71.5
73.4
0.34
118
1151
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
61
0.82
0.08
1.0
1.3
—
1.3
—
0
5
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
39
409
0.95
0.08
4.1
3.5
ng/l
762.8
715.0
0.07
30
319
(3000492) Spirometry study
36
342
1.06
0.08
1.3
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
65
0.77
0.08
1.2
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
93
906
1.03
0.08
1.6
1.7
pmol/l
104.4
96.8
0.83
53
480
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
42
439
0.95
0.08
1.7
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
22
205
1.08
0.08
3.2
4.2
%
1.9
1.6
0.38
22
183
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
11
98
1.13
0.07
1.6
1.4
pmol/l
62.8
51.6
0.44
11
93
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
74
1.08
0.07
2.1
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
8
76
1.05
0.07
1.1
1.5
u/l
19.9
17.1
—
8
63
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
7
80
0.87
0.07
1.1
1.3
—
38.6
—
0
8
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
84
0.83
0.07
1.0
1.2
—
2.7
—
0
10
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
118
1.11
0.07
1.9
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
91
0.88
0.07
1.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
92
0.87
0.07
2.9
2.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
24
226
1.07
0.06
1.0
1.2
—
134.0
—
0
5
(3007566) Smooth muscle Ab [Titer] in Serum
8
95
0.84
0.06
1.3
1.3
—
81.7
—
0
12
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
43
414
1.04
0.06
3.4
2.6
e6/l
0.8
0.7
0.08
23
219
(3000330) Specific gravity of Urine by Test strip
12
109
1.10
0.06
5.8
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
42
405
1.04
0.06
3.4
2.7
e6/l
3.5
3.7
0.03
23
210
(3012516) Albumin [Mass/volume] in Urine
51
526
0.97
0.05
2.9
3.5
mg/l
1082.7
320.0
0.33
39
364
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
287
2851
1.02
0.05
8.7
8.3
ml/min/173m2
95.3
96.3
0.30
222
2236
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
100
1.10
0.05
2.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
161
0.93
0.05
1.3
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
344
3425
1.03
0.05
8.4
8.2
u/l
26.9
27.1
0.07
334
3335
(3029937) Albumin [Presence] in Urine by Test strip
82
805
1.02
0.04
3.5
3.3
estimate
0.0
0.0
1.08
28
306
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
251
0.95
0.04
1.4
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
66
671
0.98
0.03
3.6
3.8
ph
7.4
7.4
0.25
11
118
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
67
681
0.98
0.02
2.0
2.2
mg/l
0.8
0.9
0.38
52
500
(3020682) Albumin/Creatinine [Ratio] in Urine
56
550
1.02
0.02
3.7
4.2
mg/mmol
6.3
9.9
0.53
39
377
(40768797) Stomach Pathology biopsy report
36
369
0.97
0.02
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
252
1.03
0.02
1.2
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
70
709
0.98
0.02
2.1
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
36
368
0.98
0.01
1.8
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
66
667
0.99
0.01
1.4
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
12
114
1.05
0.00
7.2
10.2
mg/l
1.2
1.2
0.13
12
108
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
116
0.95
0.00
1.2
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
15
156
0.96
0.00
2.7
4.1
ug/l
204.4
9.6
—
9
120
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
102
1014
1.01
0.00
1.7
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
126
1254
1.01
0.00
1.9
2.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
11
108
1.02
0.00
2.8
4.9
g/l
3.0
3.3
0.42
11
103
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
13
128
1.02
0.00
1.9
1.9
ug/l
7.4
6.1
0.16
13
117
(3036489) Thrombin time
13
128
1.02
0.00
2.5
4.1
s
22.8
21.0
0.90
13
112
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
18
179
1.01
0.00
4.1
2.1
u/ml
45.7
30.8
0.27
18
169
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
24
241
1.00
0.00
1.6
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
97
1.03
0.00
1.4
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
112
1117
1.00
0.00
1.7
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
235
1.02
0.00
1.8
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
104
0.96
0.00
1.2
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
134
0.97
0.00
3.9
2.7
e6/l
0.3
0.1
0.65
13
128
(4010399)
16
164
0.97
0.00
1.3
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
35
354
0.99
0.00
2.1
2.3
u/l
1123.7
4801.1
1.56
15
149
(3002256) Pathology report gross observation
35
346
1.01
0.00
1.1
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
3.5
u/ml
61.1
3.4
—
5
45
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.2
1.5
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
7
0.00
0.00
0.0
1.7
—
181.3
—
0
7
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
8
83
0.96
0.00
1.0
1.6
mg/l
492.0
362.3
—
8
77
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
66
0.91
0.00
1.0
1.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
68
0.88
0.00
1.0
1.2
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.8
—
0
5
(3024263) Appearance of Synovial fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
2.7
—
0
7
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
64
0.94
0.00
1.2
1.7
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
3.2
—
102.8
—
0
5
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
9
93
0.97
0.00
1.1
1.2
—
2.6
—
0
5
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
8.1
—
25.7
—
0
7
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.4
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
69
0.87
0.00
1.3
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
5
58
0.86
0.00
1.8
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
24.8
—
0
9
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
21.7
—
0.4
—
0
7
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
54
0.93
0.00
3.0
1.9
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
64
0.94
0.00
13.7
2.6
nmol/l
0.6
0.8
—
6
54
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CLEFT_PALATE and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CLEFT_PALATE | 1.685 [1.24, 2.3] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 51 out of 1196 males with Q17_CLEFT_PALATE died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CLEFT_PALATE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.31% |
| 5 | No data | 2.108% |
| 10 | No data | 4.96% |
| 15 | No data | 9.258% |
| 20 | No data | 15.23% |
Relationships between endpoints
↥Index endpoint: Q17_CLEFT_PALATE – Cleft palate
GWS hits: 5
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data